Cu isotope ratios are meaningful in ovarian cancer diagnosis.

[1]  M. Leybourne,et al.  Copper Isotopic Analysis in Geological and Biological Reference Materials by MC‐ICP‐MS , 2020, Geostandards and Geoanalytical Research.

[2]  R. Polishchuk,et al.  Activity and Trafficking of Copper-Transporting ATPases in Tumor Development and Defense against Platinum-Based Drugs , 2019, Cells.

[3]  Jian Lu,et al.  Body mass index as an independent risk factor for inferior vena cava resection during thrombectomy for venous tumor thrombus of renal cell carcinoma , 2019, World Journal of Surgical Oncology.

[4]  M. Gottesman,et al.  Revisiting the role of ABC transporters in multidrug-resistant cancer , 2018, Nature Reviews Cancer.

[5]  W. Maret,et al.  The Functions of Metamorphic Metallothioneins in Zinc and Copper Metabolism , 2017, International journal of molecular sciences.

[6]  F. Albarède,et al.  Copper transporters are responsible for copper isotopic fractionation in eukaryotic cells , 2017, Scientific Reports.

[7]  F. Albarède,et al.  Medical applications of isotope metallomics , 2017 .

[8]  S. Lutsenko Copper trafficking to the secretory pathway. , 2016, Metallomics : integrated biometal science.

[9]  F. Ramadhan,et al.  Validity of Cancer Antigen-125 (CA-125) and Risk of Malignancy Index (RMI) in the Diagnosis of Ovarian Cancer. , 2015, Oman medical journal.

[10]  F. Albarède Metal Stable Isotopes in the Human Body: A Tribute of Geochemistry to Medicine , 2015 .

[11]  Joshy George,et al.  Whole–genome characterization of chemoresistant ovarian cancer , 2015, Nature.

[12]  F. Albarède,et al.  Copper isotope effect in serum of cancer patients. A pilot study. , 2015, Metallomics : integrated biometal science.

[13]  P. Hainaut,et al.  Natural variations of copper and sulfur stable isotopes in blood of hepatocellular carcinoma patients , 2015, Proceedings of the National Academy of Sciences.

[14]  F. Albarède,et al.  Density functional theory estimation of isotope fractionation of Fe, Ni, Cu, and Zn among species relevant to geochemical and biological environments , 2014 .

[15]  F. Albarède,et al.  Copper isotope fractionation between aqueous compounds relevant to low temperature geochemistry and biology , 2013 .

[16]  F. Albarède,et al.  Isotopic evidence of unaccounted for Fe and Cu erythropoietic pathways. , 2011, Metallomics : integrated biometal science.

[17]  R. Bast CA 125 and the detection of recurrent ovarian cancer , 2010, Cancer.

[18]  Anil K Sood,et al.  Therapeutic Targeting of ATP7B in Ovarian Carcinoma , 2009, Clinical Cancer Research.

[19]  Nicole Urban,et al.  CA125 in ovarian cancer. , 2007, Biomarkers in medicine.

[20]  T. Ishikawa,et al.  The roles of copper transporters in cisplatin resistance , 2007, Cancer and Metastasis Reviews.

[21]  M. Iskra,et al.  Analysis of serum copper and zinc concentrations in cancer patients , 2007, Biological Trace Element Research.

[22]  S. Howell,et al.  Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs. , 2005, Critical reviews in oncology/hematology.

[23]  D. Alberts,et al.  Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  Francis Albarède,et al.  Precise analysis of copper and zinc isotopic compositions by plasma-source mass spectrometry , 1999 .

[25]  J. Turnlund Human whole-body copper metabolism. , 1998, The American journal of clinical nutrition.

[26]  M. Olivares,et al.  Limits of metabolic tolerance to copper and biological basis for present recommendations and regulations. , 1996, The American journal of clinical nutrition.

[27]  E. Frieden,et al.  Ceruloplasmin: the copper transport protein with essential oxidase activity. , 2006, Advances in enzymology and related areas of molecular biology.